New oligo-β-(1,3)-glucan derivatives as immunostimulating agents
Authors:
- Vaclav VětvičkaVVVaclav Větvička
- Jean-Claude YvinJYJean-Claude Yvin
- Vincent FerrièresVincent Ferrières
- 1 January 2010
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (1) , 348-357
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapyJournal of Experimental & Clinical Cancer Research, 2008
- Higher order structure of (1,3)‐β‐D‐glucans and its influence on their biological activities and complexation abilitiesBiopolymers, 2008
- β-Glucans, History, and the Present: Immunomodulatory Aspects and Mechanisms of ActionJournal of Immunotoxicology, 2008
- Medicinal importance of fungal β-(1→3), (1→6)-glucansMycological Research, 2007
- Polysaccharide biological response modifiersImmunology Letters, 2006
- Glycosyl Phosphonium Halide as a Reactive Intermediate in Highly α-Selective GlycosylationBulletin of the Chemical Society of Japan, 2005
- Glucan-like synthetic oligosaccharides: iterative synthesis of linear oligo-β-(1,3)-glucans and immunostimulatory effectsGlycobiology, 2004
- Dectin-1 Mediates the Biological Effects of β-GlucansJournal of Experimental Medicine, 2003
- 3,4,6-Tri-O-benzyl-.alpha.-D-arabino-hexopyranos-2-ulosyl Bromide: A Versatile Glycosyl Donor for the Efficient Generation of .beta.-D-Mannopyranosidic LinkagesThe Journal of Organic Chemistry, 1994
- Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by mouse peritoneal macrophages: A flow cytometric studyInternational Journal of Immunopharmacology, 1989